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Edited by Sandro SonninoAbstract Existing protocols show a variety in the percentage of
neurons that can be generated from mouse embryonic stem (ES)
cells. In the current study, we compared eﬀects of various
diﬀerentiating conditions, including gelatin and poly-L-ornithine/
ﬁbronectin coatings, and NGF and 17-estradiol treatments on
the total yield of neurons, as well as, neurite growth and
branching. Here, we show that combination of ﬁbronectin
coating with 17-estradiol increased number of generated neurons
over 50%. Poly-L-ornithine/ﬁbronectin increased the percent of
neurons in all cultures, suggesting its direct inﬂuence on
neurogenesis. Addition of 17-estradiol reduced mean neurite
length in culture, but signiﬁcantly increased branching. Our
results indicate a substrate-dependent regulation of estrogen-
induced ES cells diﬀerentiation into neuronal cells.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Branching1. Introduction
Embryonic stem (ES) cells derived from a blastocyst diﬀer-
entiate into a variety of cell types. Experiments have shown that
ES cells can be maintained in culture over a year (more than 250
passages) while retaining their phenotype and ability to diﬀer-
entiate [1]. Because ES cells may be easily cultured, propagated
and genetically manipulated, they may prove to be a good
source of specialized cells for transplantation applications.
Targeted diﬀerentiation of stem cells into speciﬁc neuronal and
glial phenotypes holds promise to develop into a powerful ap-
proach for treatment of neurological disorders and injuries.
There are reports showing that ES cells can be successfully used
for treatment of animal models of spinal cord injury [2,3], and
Parkinson’s disease [4–6]. However, generation of speciﬁc
neuronal populations in suﬃcient quantities for transplantation
represent a signiﬁcant practical problem. Several protocols have
been successfully used to generate neurons from stem cells.
These include treatments with retinoic acid [7], ascorbic acid
[5,6], BMP-2 [8], and Shh proteins [9]. However, the reported
percentile of cells expressing neuronal markers is usually low
and does not exceed 30%. Diﬀerent conditions that may aﬀect* Corresponding author. Fax: +1-252-744-3460.
E-mail address: murashoval@mail.ecu.edu (A.K. Murashov).
URL: http://www.ecu.edu/physio/labakm
0014-5793/$22.00  2004 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2004.05.042ES cell diﬀerentiation include: cell culture media, cell ﬂask
coating and growth factors. In the current study, we compared
the eﬀects of various diﬀerentiating conditions, including gela-
tin and ﬁbronectin coatings, and NGF and 17b-estradiol
treatments on a total yield of neurons, as well as, on neurite
growth and branching. We found that poly-L-ornithine/ﬁbro-
nectin induces neuronal phenotype. A combination of poly-L-
ornithine/ﬁbronectin with 17b-estradiol reduced mean neurite
length in culture, but signiﬁcantly increased branching. These
results demonstrate a substrate-dependent regulation of estro-
gen-induced neuronal diﬀerentiation of ES cells.2. Materials and methods
2.1. Cell culture and diﬀerentiation
Mouse ES cells (WW6, American Type Culture Collection, Ma-
nassas, VA) were routinely passaged every two days in gelatinized 25
cm ﬂasks at a density 1 106 cells in DMEMwith high glucose (Stem
Cells Technologies) in the presence of ESGRO (recombinant mouse
LIF) 1000 U/ml (Chemicon International, Temecula, CA) and 1·
penicillin/streptomycin (Gibco, Invitrogen Corporation, Carlsbad,
CA). For induction of diﬀerentiation a modiﬁed 4)/4+ protocol [7]
was employed. ES cells were ﬁrst harvested from conﬂuent ﬂask. Cells
were washed with Ca2þ/Mg2þ-free D-PBS, trypsinized (2 ml of 0.25%
trypsin/EDTA) for 2–3 min, resuspended in 5 ml of IMEM-10% dif-
ferentiation fetal bovine serum (FBS) (Gibco) and centrifuged (1200
rpm, 8 min). Approximately 1/4 (3 106 cells) of ES cells from one
nearly conﬂuent (85–90%) 25 cm ﬂask was resuspended in 10 ml of
diﬀerentiation medium (DM) (IMDM, 15% FBS, 2 mM L-glutamine,
0.1 mM non-essential amino acids, penicillin 100 U/ml, streptomycin
100 lg/ml) and cultured in 100 mm non-adhesive Petri dishes to allow
cells to aggregate and form embryoid bodies (EBs). Medium was re-
placed every two days. After four days EBs were gently transferred to a
15 ml tube, and allowed to stand until the EBs settled to the bottom
(about 10 min). Medium was replaced and EBs were transferred back
into the original dish by pipetting. At day 5 all trans-retinoic acid
(Sigma, St. Louis, MO) (1 106 M) was added and the cells were
cultured for another four days. After four days with retinoic acid, EBs
were trypsinized and gently resuspended. Cells were plated on gelatin
or poly-L-ornithine/ﬁbronectin coated glass cover slips (275 000 cells
per cover slip) in DM medium. The next day the medium was changed
and NGF(100 ng/ml, Sigma) or 17b-estradiol (1 108 M, Sigma)
were added. The medium was changed and the treatment was repeated
on the following day. Cells were ﬁxed with 4% paraformaldehyde in
PBS (pH 7.4) and processed for immunocytochemistry.
2.2. Immunocytochemistry
Immunocytochemical staining was performed according to our
laboratory protocol, as described previously [10]. Cells were ﬁrst
washed for 5 min in PBST (phosphate-buﬀered saline with 0.3% Triton
X-100) and then incubated for 10 min in ice-cold 80% methanol con-
taining 0.3% hydrogen peroxide to abolish endogenous peroxidase
activity. Cells were then washed three times in PBST for 5 min, thenation of European Biochemical Societies.
Fig. 1. ES cell diﬀerentiation. Upper panel: Phase contrast of ES cell
aggregates plated on gelatin or poly-L-ornithine/ﬁbronectin coated
glass cover slips for 24 h. (A) Irregular shape of ES cells attached to
gelatin substrate. (B) Many round-shaped cells with growing neurites
are visible on poly-L-ornithine/ﬁbronectin coated glass. Middle panel:
MAP-2 positive cells on gelatin glass cover slips visualized by imm-
unoperoxidase staining. (C) Few short neurites are visible in culture
without any treatment. (D) Increase in neurite growth in the presence
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Blocking Kit, Vector Laborastories, Burlingame, CA), rinsed with
PBS, followed by a 1 h incubation with blocking solution, 10% normal
goat serum in PBST. Cells were incubated with primary rabbit anti-
MAP-2 polyclonal antibodies (greatest immunoreactivity with neuro-
nal MAP-2A and MAP-2B) (Chemicon) at a 1:2000 dilution overnight
at 4 C. Subsequently, they were washed three times for 10 min with
PBST and incubated with secondary biotinylated antibodies for 1 h.
Cells were washed again three times in PBST for 10 min and incubated
for 2 h in Elite ABC reagent (avidin-biotinylated horseradish peroxi-
dase complex, Vector Laboratories). Cells antigens were visualized
with a DAB Substrate Kit for Peroxidase (Vector Laboratories).
Staining without primary or secondary antibodies served as negative
controls (results not shown). After staining, coverslips were air dried,
incubated in histoclear two times for 15 min and permanently mounted
with Permount (Fisher Scientiﬁc). Images were taken using a Nikon
Eclipse TS100 inverted microscope with attached Kodak DC290 dig-
ital camera and an Olympus IMT-2 inverted microscope with attached
Spot digital camera.
2.3. Quantiﬁcation of neurons, and measurement of neurite length and
neurite branching
Quantiﬁcation of neuron counts and measurement of neurite length
and branching was performed according to protocol described else-
where [11]. To visualize neuronal morphology, cells were stained with
neuron-speciﬁc anti-MAP-2 polyclonal antibodies (Chemicon). Images
of the cells were taken at 40· magniﬁcation using Spot digital camera
and Spot Software v.3.5.8 (Diagnostic Instruments, Sterling Heights,
MI). 10–30 individual images were taken from each cover glass. The
number of neurons and the total number of cells were counted using
NIH ImageJ software (NIH). Neurite length was measured only in
neurons which were completely distinguishable from neighboring cells.
ImageJ software was used for tracing neurites, as well as, for calcu-
lation of neurite length. The number of neurite branches was counted
manually after the entire neuron was traced. Processes initiated from
the cell body were scored if they extended greater than 1 cell body in
length from the neurite, and secondary and higher order branches of
the neurite were scored after a branch point. All experiments were
repeated three times.of 17b-estradiol added for 48 h. Lower panel: Tracings of neurons in
ImageJ (NIH Image) program. (E) Bipolar cells can be observed on
poly-L-ornithine/ﬁbronectin coated glass cover slips without any
treatment. (F) Increase in neurite branching after 17b-estradiol was
added for 48 h.2.4. Statistical analysis
Statistical analysis was performed with one-way ANOVA New-
man–Keuls Multiple Comparison Test using Prism (GraphPad Prism
version 3.00 for Windows, GraphPad Software, San Diego, CA).3. Results
We examined live cultures with inverted microscope 24 h
after plating ES cells onto gelatin or poly-L-ornithine/ﬁbro-
nectin coated glass cover slips. The analysis revealed a re-
markable diﬀerence between ES cells growing on gelatin and
on poly-L-ornithine/ﬁbronectin coated cover slips. On gelatin
cover slips, aggregates of ES cells had an irregular or spindle-
like shape with fewer processes (Fig. 1A). On poly-L-ornithine/
ﬁbronectin coated cover slips the cells shape was predomi-
nantly round and aggregates showed striking neurite
outgrowth (Fig. 1B). These data showed that poly-L-ornithine/
ﬁbronectin substrate encourages both neuronal diﬀerentiation
and neurite outgrowth of ES cells.
The cultures were then treated with either NGF (100 ng/ml)
or 17b-estradiol (1 108 M) for 48 h. Cells were ﬁxed with
4% paraformaldehyde in PBS (pH 7.4) and processed for im-
munocytochemistry for MAP-2, a neuron-speciﬁc marker.
Immunohistochemical staining revealed a signiﬁcant increase
in the number of MAP-2-immunopositive cells on poly-L-or-
nithine/ﬁbronectin versus gelatin coating (Fig. 2, upper panel).
Interestingly, both NGF and 17b-estradiol treatments mark-
edly increased number of neurons on poly-L-ornithine/ﬁbro-nectin (P < 0:001), but not on gelatin. Statistical analysis with
ANOVA of the number of neurons generated after treatment
with NGF or 17b-estradiol on gelatin and poly-L-ornithine/
ﬁbronectin showed that the increase in number of neurons was
possibly due to poly-L-ornithine/ﬁbronectin coating rather
than to treatments with NGF or 17b-estradiol.
Comparison of mean neurite lengths demonstrated the ex-
pected increase of neurite growth (P < 0:001) on poly-L-orni-
thine/ﬁbronectin in compare to gelatin. Suprisingly, both NGF
and 17b-estradiol increased mean neurite length on gelatin
coating, but signiﬁcantly reduced it on poly-L-ornithine/
ﬁbronectin (Fig. 2, middle panel). A small, but signiﬁcant
increase in neurite growth on gelatin in the presence of 17b-
estradiol can be also observed in the microphotograph shown
in Fig. 1D. What was interesting here is that poly-L-ornithine/
ﬁbronectin, which enhances neurite growth of diﬀerent neural
cell types [12,13], did not support neurite growth of diﬀeren-
tiating ES cells in the presence of NGF or 17b-estradiol.
We further examined whether NGF and 17b-estradiol may
eﬀect neurite branching. Quantiﬁcation of branching revealed
no diﬀerences in the mean number of branches per cell on gel-
atin or poly-L-ornithine/ﬁbronectin coatings (Fig. 2, lower pa-
nel). However, NGF treatment elicited a small non-signiﬁcant
Fig. 2. Poly-L-ornithine/ﬁbronectin increases percent of neurons and
mean neurite length, while 17b-estradiol treatment induces branching.
Upper panel: percent of neurons. Middle panel: mean neurite length
(lm). Lower panel: mean number of branches. G, gelatin coating; F,
poly-L-ornithine/ﬁbronectin coating; G+NGF, gelatin coating plus
NGF treatment; G+E2, gelatin coating plus 17b-estradiol; F+NGF,
poly-L-ornithine/ﬁbronectin coating plus NGF treatment; F+E2,
poly-L-ornithine/ﬁbronectin coating plus 17b-estradiol.
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gelatin and poly-L-ornithine/ﬁbronectin. Treatment with 17b-
estradiol produced a striking induction of neurite branching on
both gelatin and poly-L-ornithine/ﬁbronectin, which could be
observed in ImageJ tracings shown in Fig. 1F. Statistical
analysis by ANOVA of mean number of branches of 17b-es-
tradiol treated cells on gelatin and poly-L-ornithine/ﬁbronectin
revealed that most of the increase in neurite branching was
primarily due to 17b-estradiol treatment, rather than to sub-
strate coating (Fig. 2, lower panel). Together with results on
neurite length, these data indicated that the observed increase inestrogen-stimulated neurite outgrowth was not due to increase
in neurite elongation, but instead to neurite branching.4. Discussion
Our results illustrate an interesting interaction between
trophic factors and extracellular matrix molecules in regulating
diﬀerentiation of ES cells. Here, we showed that poly-L-orni-
thine/ﬁbronectin coating alone can generate over 40% neurons.
Fibronectin is a part of extracellular matrix in the central
nervous system and is one of the most commonly used sub-
strates for neuronal cell cultures providing adequate support
for cell growth [12]. It has been recently shown that ﬁbronectin
may also act as a morphogen inducing neuronal diﬀerentiation
[13]. In our unpublished observation we found that embryoid
bodies treated for four days with ﬁbronectin (10 lg/ml) added
directly to the media generated neurons in a pattern similar
to retinoic acid treatment. This indicates that ﬁbronectin may
be used as a powerful morphogen for ES cell neuronal
diﬀerentiation.
The most striking observation was the interaction between
poly-L-ornithine/ﬁbronectin coating and trophic factors. NGF
and 17b-estradiol produced small but signiﬁcant increases in
neurite length on gelatin, and a dramatic decrease on poly-L-
ornithine/ﬁbronectin. Therefore, the ability of ﬁbronectin to
stimulate neurite growth was inhibited in the presence of either
NGF or 17b-estradiol. These results demonstrate a substrate-
dependent regulation of NGF- and estrogen-induced neurite
elongation. At the same time both NGF and, in particular,
17b-estradiol promoted neurite branching. 17b-estradiol sig-
niﬁcantly increased neurite branching on both gelatin and
poly-L-ornithine/ﬁbronectin coatings. NGF had a similar
trend, however, it failed to reach statistical signiﬁcance in our
experiments. What was surprising here is that 17b-estradiol on
poly-L-ornithine/ﬁbronectin substrate signiﬁcantly decreased
mean neurite length while signiﬁcantly inducing branching.
This may indicate accelerated diﬀerentiation of neurons which
have shorter but better branched out neurites. Based on our
data, we hypothesize that 17b-estradiol accelerates both dif-
ferentiation and maturation of neuronal cells.
It is well known that estrogen may aﬀect cell growth, pro-
liferation, and diﬀerentiation [14]. In the nervous system es-
trogen has a variety of beneﬁcial eﬀects including protection
from apoptosis [15], accelerated peripheral nerve regeneration
[16], and increased neurite outgrowth [17]. It has been recently
reported that 17b-estradiol may increase the ratio of neurons to
glia cells in neural stem cells, suggesting an inﬂuence on neu-
rogenesis during embryonic development [18]. In our report, we
provide evidence of 17b-estradiol diﬀerentiating action on ES
cells. To the best of our knowledge this is the ﬁrst observation
of morphogen-like eﬀect of 17b-estradiol on induction of neu-
ronal phenotype in ES cell culture. Moreover, our results
demonstrate a substrate-dependent regulation of 17b-estradiol
induced ES cells diﬀerentiation. Combination of 17b-estradiol
with poly-L-ornithine/ﬁbronectin may provide a beneﬁcial
growing condition for neuronal induction of ES cells.Acknowledgements: This work was supported in part by research grant
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